Robert W. Middleton

Milkhaus Laboratory, Inc. provides organic chemical products. Its products are used for urological health, skin care, wound care and other healthcare concerns. The company develops drugs based on the theory of systemic signaling, which postulates that therapeutic molecules can send genomic or cellular signals that disrupt the dysfunctional signals causing disease and allow the body to restore healthy signals. Milkhaus Laboratory was founded by Robert W. Middleton in 1993 and is headquartered in Providence, RI.

Applied Semiconductor, Inc. develops semiconductor technology. The company's trademark product, Zeta, helps prevent corrosion of conductive materials and hard marine fouling. It was founded by David B. Dowling in 1998 and is located in New York, NY.

New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY.

Velico Medical, Inc. operates as a pre-clinical medical technology company that develops and commercializes products for use in preparing and storing platelets and plasma, including a companion instrument and disposable product for spray drying plasma. Its products include FrontlineODP (on demand Plasma) and FrontlinePPS (Platelet Protection System). The company was founded by Robert W. Middleton and Cabot G. L. Henderson in 1991 and is headquartered in Beverly, MA.

Compositech Ltd. Engages in developing and marketing superior copper-clad fiberglass epoxy laminates used to make printed circuit boards required by the electronics industry. The company was founded by Fred E. Klimpl in 1984 and is headquartered in Woodbury, NY.

Pharmaco-Kinesis Corp. provides research and development services. Its products include smart drug delivery systems and associated advanced devices to measure biological responses; and Magnetic Breather Pump, a device in the field of local drug delivery that delivers a remotely programmable metronomic combination of tumor fighting medications in single implantable system, as well as is used for the treatment of malignant gliomas and other aggressive brain tumors. The company was founded by John Shachar, Frank Adell, Eli Gang and Thomas C. Chen in 2006 and is headquartered in Los Angeles, CA.